(PharmaNewsWire.Com, November 11, 2021 ) Growth in the cryotherapy market is primarily driven by factors such as the growing incidences of sports injuries, cardiac diseases, & cancers, and technological advancements in cryotherapy technology.
The study involved four major activities to estimate the current size of the cryotherapy market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size.
According to the new market research report “Cryotherapy Market by Product (Cryosurgery Devices, Localized Cryotherapy Devices, Cryosaunas), Application (Surgical Application, Pain Management, Health & Beauty), End User (Hospitals & Specialty Clinics, Spas) – Global Forecast to 2024″, published by MarketsandMarkets™, the Cryotherapy Market is expected to reach USD 319 million by 2024 from USD 206 million in 2019, at a CAGR of 9.1%
The rising incidence of sports injuries, cardiac conditions, and cancers and the growing demand for minimally invasive procedures are the key drivers of the Cryotherapy Market. Technological advancements in cryotherapy equipment and its growing popularity in the beauty, wellness, and fitness industries are also supporting the growth of this market.
Cryosurgery devices are estimated to account for the largest share of the cryotherapy product market in 2018
The Cryotherapy Market is segmented on the basis of products into cryosurgery devices, localized cryotherapy devices, and cryochambers & cryosaunas. The cryosurgery devices segment is further divided into tissue contact probes, tissue spray probes, and epidermal & subcutaneous cryoablation devices. The cryosurgery devices segment held the largest share of the Cryotherapy Market in 2018. The technological advancements in cryoablation technologies and the therapeutic advantages of cryoablation over other ablation modalities are the major factors driving the growth of this product segment.
Hospitals & specialty clinics are the primary end users of the global Cryotherapy Market
The market is segmented into hospitals & specialty clinics, cryotherapy centers, and spas & fitness centers on the basis of end users. The hospitals & specialty clinics segment estimated to command the largest share of the market in 2019 and this segment is also projected to register the highest CAGR owing to the increasing adoption of cryoablation for cancer and cardiac diseases. The affordability and safety offered by cryosurgery over traditional surgery and the rising prevalence of CVDs, cancer, & sports injuries are expected to increase the adoption of cryotherapy in hospitals & specialty clinics.
The APAC Cryotherapy Market to grow at the highest CAGR during the forecast period
While North America is expected to dominate the global Cryotherapy Market in 2019, the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the booming medical tourism in the region, the growing geriatric population in Japan, and the rising prevalence of cancer in India.
The major players operating in the Cryotherapy Market include Medtronic (Ireland), Galil Medical (US), and CooperSurgical (US). Other players involved in this market include Impact Cryotherapy (US), Zimmer MedizinSysteme (Germany), Metrum Cryoflex (Poland), Brymill Cryogenic Systems (UK), Erbe Elektromedizin (Germany), CryoConcepts (US), US Cryotherapy (US), Professional Products (US), and Kriosystem Life (Poland).
Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting
Browse Related Reports:
Ablation Technology Market by Product (Radiofrequency, Ultrasound (ESWL, HIFU), Laser, Electrical (Argon Plasma, IRE), Cryotherapy, Microwave, Hydrothermal) & Application (Cardiovascular, Cancer, Pain Management, Orthopedics) – Global Forecasts to 2021
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
